EyePoint Plc (EYPT)
18.01
-0.31
(-1.69%)
USD |
NASDAQ |
Mar 04, 16:00
18.00
-0.01
(-0.06%)
After-Hours: 20:00
EyePoint Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Ocular Therapeutix, Inc. | -2.839M |
| Viking Therapeutics, Inc. | 75.61M |
| Janux Therapeutics, Inc. | 29.54M |
| Tango Therapeutics, Inc. | 47.48M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -213.59M |
| Free Cash Flow Per Share (Quarterly) | -0.8573 |
| Free Cash Flow to Equity (Quarterly) | -61.60M |
| Free Cash Flow to Firm (Quarterly) | -60.15M |
| Free Cash Flow Yield | -16.20% |